Proteomic profiling of gemcitabine-resistant pancreatic cancer cells unravels microtubule-associated protein 2 overexpression, that correlated to poorer survival but also to increased sensitivity to nab-paclitaxel

AISP 2019, Verona 21 September 2019

Presentation by Mjriam Capula, who was awarded for the Best Oral Presentation in preclinical/translational research

Some results of this study have been published in Therapeutic Advances in Medical Oncology:

PDF file: Mjriam Capula – Presentazione AISP 2019